Xia Wen Shui

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND The purpose of this study was to assess the in vivo ability of glucosaminic acid-cobalt (II) chelate to reduce glycemia. METHODS Different concentrations of chelate solution were administrated to mice with diabetes induced by streptozotocin. RESULTS Daily oral administration of chelate solution 0.4 mL at various concentrations (0.32-0.4 g/mL)(More)
  • 1